Bictegravir/emtricitabine/tenofovir-alafenamideDepression and renal impairment: 4 case reports

被引:0
|
作者
机构
关键词
D O I
10.1007/s40278-025-79582-7
中图分类号
学科分类号
摘要
引用
收藏
页码:62 / 62
相关论文
共 50 条
  • [45] Cerebrospinal fluid exposure to bictegravir/emtricitabine/tenofovir in HIV-1-infected patients with CNS impairment
    Gele, Thibaut
    Cheret, Antoine
    Gordon, Alicia Castro
    Nkam, Lionelle
    Furlan, Valerie
    Pallier, Coralie
    Becker, Pierre-Hadrien
    Catalan, Pilartxo
    Goujard, Cecile
    Taburet, Anne-Marie
    Gasnault, Jacques
    Gouget, Helene
    Barrail-Tran, Aurelie
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2021, 76 (12) : 3280 - 3285
  • [46] Utilization of bictegravir/emtricitabine/tenofovir alafenamide in patients with end-stage renal disease on hemodialysis
    Sidman, Eric F.
    Ondrush, Nicole M.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2023, 80 (09) : E92 - E97
  • [49] Elvitegravir/cobicistat/emtricitabine/tenofovir DF in HIV patients with renal impairment
    Post, F.
    Andrade-Villanueva, J.
    Fisher, M.
    Winston, J.
    Liu, Y.
    Zhong, L.
    Cheng, A.
    Rhee, M.
    Szwarcberg, J.
    HIV MEDICINE, 2014, 15 : 115 - 115